Home » Topics » Regulatory » Patents

Patents
RSS

Aryl-ureido anticancer agents reported by Universite Laval

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

MK7634 described in world patent

Aug. 9, 1996

A-76202: Alpha-glucosidase/sucrase-isomaltase complex inhibitor from Sankyo

Aug. 9, 1996

Antiviral pyrimidine derivatives described by Nippon Shoji

Aug. 9, 1996

Novel oxazolidinone antibacterial agents reported by Bayer

Aug. 9, 1996

Antibacterial peptides from Sanwa Kagaku

Aug. 9, 1996

Beta-Lactamase inhibitors for treatment of penicillin-resistant infections

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...